Universitätsklinikum Köln

Fatal complications in juvenile diabetes mellitus Letale Komplikationen bei juvenilem Diabetes mellitus (2019) Feld K, Kamphausen T, Jübner M, Rothschild MA, Banaschak S Journal article Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article A Multi-Platform Treatment Planning Benchmark Study for Spinal Radiosurgery (2019) Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Cilla S, et al. Conference contribution Tumour mutational burden analysis: implementation in routine diagnostics (2019) Kroeze L, Kamping E, Von Rhein D, Jansen E, De Voer R, Barberis M, Botling J, et al. Conference contribution Nab-paclitaxel improves disease-free survival in early breast cancer: GBG 69–Geparsepto (2019) Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, et al. Journal article Postoperative pain in small-for-gestational age infants after hernia repair, orchidopexy and urethral reconstruction surgery: A pilot study (2019) Schüssler SC, Kußmann F, Fahlbusch FB, Münster T, Hirsch K, Carbon R, Albrecht S, et al. Journal article A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: Clinical results and biomarker analysis of GeparNuevo study (2019) Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al. Journal article Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution